SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Foster N.))
 

Search: (WFRF:(Foster N.)) > (2000-2004) > Autologous stem cel...

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

de Kleer, I. M. (author)
Brinkman, D. M. (author)
Ferster, A. (author)
show more...
Abinun, M. (author)
Quartier, P. (author)
Van Der Net, J. (author)
ten Cate, R. (author)
Wedderburn, L. R. (author)
Horneff, G. (author)
Oppermann, J. (author)
Zintl, F. (author)
Foster, H. E. (author)
Prieur, A. M. (author)
Fasth, Anders, 1945 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik,Institute for the Health of Women and Children, Dept of Paediatrics
van Rossum, M. A. (author)
Kuis, W. (author)
Wulffraat, N. M. (author)
show less...
 (creator_code:org_t)
BMJ, 2004
2004
English.
In: Ann Rheum Dis. - : BMJ. - 0003-4967. ; 63:10, s. 1318-26
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: To evaluate the safety and efficacy of autologous stem cell transplantation (ASCT) for refractory juvenile idiopathic arthritis (JIA). DESIGN: Retrospective analysis of follow up data on 34 children with JIA who were treated with ASCT in nine different European transplant centres. Rheumatological evaluation employed a modified set of core criteria. Immunological reconstitution and infectious complications were monitored at three month intervals after transplantation. RESULTS: Clinical follow up ranged from 12 to 60 months. Eighteen of the 34 patients (53%) with a follow up of 12 to 60 months achieved complete drug-free remission. Seven of these patients had previously failed treatment with anti-TNF. Six of the 34 patients (18%) showed a partial response (ranging from 30% to 70% improvement) and seven (21%) were resistant to ASCT. Infectious complications were common. There were three cases of transplant related mortality (9%) and two of disease related mortality (6%). CONCLUSIONS: ASCT in severely ill patients with JIA induces a drug-free remission of the disease and a profound increase in general wellbeing in a substantial proportion of patients, but the procedure carries a significant mortality risk. The following adjustments are proposed for future protocols: (1) elimination of total body irradiation from the conditioning regimen; (2) prophylactic administration of antiviral drugs and intravenous immunoglobulins until there is a normal CD4+ T cell count.

Keyword

Arthritis
Juvenile Rheumatoid/immunology/*therapy
Child
Child
Preschool
Female
Follow-Up Studies
Graft Survival
Health Status Indicators
Humans
Infant
Male
Opportunistic Infections/etiology
Patient Selection
Retrospective Studies
Severity of Illness Index
Stem Cell Transplantation/adverse effects/*methods
Survival Analysis
T-Lymphocyte Subsets/immunology
Transplantation Conditioning/methods
Transplantation
Autologous
Treatment Outcome

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view